IMBDX

IMB Dx is a precision oncology company focused on developing safe and accurate cancer diagnostic and monitoring solutions. IMB Dx has created AlphaLiquid®, a minimally invasive liquid biopsy method that requires only a single blood draw to detect cancer and monitor its progression. Through AlphaLiquid®, a comprehensive tumor genomic profile is provided, along with matched treatment options and clinical trial information.